This is the most knowledgable group I've ever been associated with (23 years).more testimonials »
Today's Big Gainers: MSO, GLS, LXRX, BCRX Tuesday, September 15, 12:10 PM ET
The Home Depot (NYSE:HD) announced an agreement to develop an exclusive Martha Stewart Living (MSO) brand of home improvement products. In January, an Outdoor Living category of products will be launched, with Home Organization and Home Decor categories to follow. Shares of Martha Stewart Living advanced about 6% in morning trading Tuesday.
Genesis Lease (GLS) announced today it is in discussions with another party concerning a possible M&A transaction. The announcement came after market rumors fueled a surge in its stock price yesterday. Shares continued upward Tuesday morning, trading over 6 and a half percent higher.
Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) more than doubled in price Tuesday, after the company announced favorable results from a phase 1 clinical trial of its treatment for type 2 diabetes. Lexicon will now launch a phase 2 trial of the drug candidate.
And shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) gained over 13 and a half percent after the company announced agreements with three different partners to market and distribute its Peramvir anti-viral agent outside the U.S. The partnerships cover Brazil, Mexico, China, and Israel.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.